Skip to main content
. 2022 May 19;17(14):e202200174. doi: 10.1002/cmdc.202200174

Figure 7.

Figure 7

A) AfBP for plasmepsin targeting developed by Liu et al., including a hydroxyethyl‐based warhead (red), a rhodamine tag (blue) and a benzophenone photo‐crosslinker (green). B) MH01 AfBP used by Harbut and colleagues based on the bestatin scaffold (red), containing a biotin tag (blue) and a benzophenone photo‐crosslinker (green).